XML 76 R53.htm IDEA: XBRL DOCUMENT v3.25.3
Restatement of Financial Statements - Statement of Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance $ 19,158 $ 49,829 $ 27,283 $ 80,428
Stock-based compensation 72 184 278 463
Issuance of common stock, net of issuance costs 4,995 599 [1] 7,495 2,434 [2]
Surrender of common stock for taxes due on vesting     (93) (31)
Net loss (4,655) (12,677) (24,460) (45,359)
Balance 25,962 37,935 25,962 37,935
Common Shares        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance $ 137 $ 93 $ 96 $ 89
Balance (in shares) 136,786,129 92,629,246 95,661,347 89,030,436
Common stock issued for vested restricted stock units (in shares)     577,529 196,991
Issuance of common stock, net of issuance costs $ 11 $ 1 [1] $ 27 $ 5 [2]
Issuance of common stock, net of issuance costs (in shares) 11,111,108 1,230,180 [1] 26,736,108 4,708,993 [2]
Surrender of common stock for taxes due on vesting (in shares)     (283,642) (76,994)
Balance $ 162 $ 94 $ 162 $ 94
Balance (in shares) 162,102,083 93,859,426 162,102,083 93,859,426
Additional Paid-in Capital        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance $ 126,958 $ 114,049 $ 115,319 $ 111,970
Stock-based compensation 72 184 278 463
Issuance of common stock, net of issuance costs 4,984 598 [1] 7,468 2,429 [2]
Surrender of common stock for taxes due on vesting     (93) (31)
Balance 138,392 114,831 138,392 114,831
Retained Earnings (Accumulated Deficit)        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance (100,882) (57,258) (81,077) (24,576)
Net loss (4,655) (12,677) (24,460) (45,359)
Balance (105,537) (69,935) (105,537) (69,935)
Treasury Stock        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance (5,884) (5,884) (5,884) (5,884)
Balance (5,884) (5,884) (5,884) (5,884)
Accumulated Other Comprehensive Loss        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance (1,171) (1,171) (1,171) (1,171)
Balance $ (1,171) (1,171) $ (1,171) (1,171)
As Previously Report        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   67,021   96,693
Stock-based compensation   184   463
Issuance of common stock, net of issuance costs   599   2,434
Surrender of common stock for taxes due on vesting       (31)
Net loss   (10,495)   (42,250)
Balance   57,309   57,309
As Previously Report | Common Shares        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   $ 93   $ 89
Balance (in shares)   92,629,246   89,030,436
Common stock issued for vested restricted stock units (in shares)       196,991
Issuance of common stock, net of issuance costs   $ 1   $ 5
Issuance of common stock, net of issuance costs (in shares)   1,230,180   4,708,993
Surrender of common stock for taxes due on vesting (in shares)       (76,994)
Balance   $ 94   $ 94
Balance (in shares)   93,859,426   93,859,426
As Previously Report | Additional Paid-in Capital        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   $ 114,049   $ 111,970
Stock-based compensation   184   463
Issuance of common stock, net of issuance costs   598   2,429
Surrender of common stock for taxes due on vesting       (31)
Balance   114,831   114,831
As Previously Report | Retained Earnings (Accumulated Deficit)        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   (40,066)   (8,311)
Net loss   (10,495)   (42,250)
Balance   (50,561)   (50,561)
As Previously Report | Treasury Stock        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   (5,884)   (5,884)
Balance   (5,884)   (5,884)
As Previously Report | Accumulated Other Comprehensive Loss        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   (1,171)   (1,171)
Balance   (1,171)   (1,171)
Restatement Impacts        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   (17,192)   (16,265)
Net loss   (2,182)   (3,109)
Balance   (19,374)   (19,374)
Restatement Impacts | Retained Earnings (Accumulated Deficit)        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Balance   (17,192)   (16,265)
Net loss   (2,182)   (3,109)
Balance   $ (19,374)   $ (19,374)
[1] No shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2025. 1,230,180 shares of the Company’s common stock were sold through the ATM Program during the three months ended September 30, 2024, for net proceeds of approximately $0.6 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—16 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.
[2] An aggregate of 25,139,655 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2025, for proceeds of approximately $8.6 million to the Company, after deducting the agent’s commissions and other fees. 4,708,993 shares of the Company’s common stock were sold through the ATM Program during the nine months ended September 30, 2024, for proceeds of approximately $2.4 million to the Company, after deducting the agent’s commissions and other fees. Please also see Note—15 Shareholder’s Equity in Item 1—Condensed Consolidated Interim Financial Statements and Notes (unaudited) for additional information.